Closed Protocols | Ptctc

top of page

Closed PTCTC Protocols

Below is a listing of past protocols that the PTCTC has been involved with.

Protocol	Status
BMT CTN Protocol 1507- Reduced Intensity Conditioning for Haploidentical Bone Marrow Transplantation in Patients with Symptomatic Sickle Cell Disease	Completed
BMT CTN Protocol 1702: Clinical Transplant-Related Long-term Outcomes of Alternative Donor Allogeneic Transplantation	Active, not recruiting
BMT CTN Protocol 0101: A Randomized Double-blind Trial of Fluconazole vs. Voriconazole for the Prevention of Invasive Fungal Infections in Allogeneic Blood and Marrow Transplant Recipients	Completed
BMT CTN Protocol 0201: A Phase III Randomized Multicenter Trial Comparing G-CSF Mobilized Peripheral Blood Stem Cell with Marrow Transplantation from HLA Compatible Unrelated Donors	Completed
BMT CTN Protocol 0301: Fludarabine-based Conditioning for Allogeneic Marrow Transplantation from HLA-compatible Unrelated Donors in Severe Aplastic Anemia	Completed
BMT CTN Protocol 0302: Initial Systemic Treatment of Acute GVHD: A Phase II Randomized Trial Evaluating Etanercept, Mycophenolate Mofetil (MMF), Denileukin Diftitox (Ontak), and Pentostatin in Combination with Corticosteroids	Completed
BMT CTN Protocol 0601: Unrelated Donor Reduced Intensity Bone Marrow Transplant for Children with Severe Sickle Cell Disease / The SCURT Study	Completed
BMT CTN Protocol 0801: A Phase II/III Randomized, Multicenter Trial Comparing Sirolimus plus Prednisone, and Sirolimus/Calcineurin Inhibitor plus Prednisone for the Treatment of Chronic Graft-versus-Host Disease	Completed
BMT CTN Protocol 0802: A Multi-Center, Randomized, Double Blind, Phase III Trial Evaluating Corticosteroids with Mycophenolate Mofetil vs. Corticosteroids with Placebo as Initial Systemic Treatment of Acute GVHD	Completed
BMT CTN Protocol 1202: Prospective Multi-Center Cohort for the Evaluation of Biomarkers Predicting Risk of Complications and Mortality Following Allogeneic HCT	Completed
BMT CTN Protocol 1204: Reduced-Intensity Conditioning for Children and Adults with Hemophagocytic Syndromes or Selected Primary Immune Deficiencies	Completed
BMT CTN Protocol 1301 (PROGRESS II): A Randomized, Multi-Center, Phase III Trial of Calcineurin Inhibitor-Free Interventions for Prevention of Graft-versus Host-Disease	Completed
BMT CTN Protocol 1501: Study Evaluating Sirolimus and Prednisone in Patients with Refined Minnesota Standard Risk, Ann Arbor 1/2 Confirmed Acute Graft-Versus-Host Disease	Completed

bottom of page